Please check your internet connection and try again.
# Calcium Acetate
## Overview
Calcium acetate is a phosphate binder. It works by binding to dietary phosphate in the gastrointestinal tract, preventing its absorption and lowering serum phosphate levels.
## Primary Indications
- Hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis.
## Adult Dosing
- **Initial dose:** 133 mg/kg/day orally, divided into 3 or 4 doses with meals.
- **Titration:** Increase dose gradually based on serum phosphate levels.
- **Maximum dose:** Not to exceed 1667 mg/kg/day orally.
- **Typical effective dose:** Ranges from 2000 mg to several grams per day, divided with meals. Dose is dependent on dietary phosphate intake and serum phosphate levels.
## Pediatric Dosing
- **Use in pediatrics:** Data is limited and dosing should be individualized under specialist guidance.
## Dose Adjustments
- No specific dose adjustments are needed for renal or hepatic impairment, as the drug is not renally excreted.
- Dose adjustments are guided by serum phosphate and calcium levels.
## Contraindications
- Hypercalcemia.
- Hypersensitivity to calcium acetate.
- Certain conditions associated with hypercalcemia (e.g., sarcoidosis, metastatic bone disease).
## Adverse Effects
- **Common:** Hypercalcemia, constipation, nausea, vomiting, diarrhea.
- **Serious:** Development of soft tissue calcification.
## Key Drug Interactions
- **Tetracyclines and fluoroquinolones:** Calcium acetate can decrease the absorption of these antibiotics. Administer at least 2 hours before or 6 hours after calcium acetate.
- **Digoxin:** Administration of oral calcium may increase the effects of digoxin.
- **Thiazide diuretics:** May increase the risk of hypercalcemia.
- **Vitamin D and its analogues:** May increase the risk of hypercalcemia.
## Monitoring
- **Serum phosphate:** Monitor regularly to guide dosing.
- **Serum calcium:** Monitor regularly to prevent and manage hypercalcemia. The goal is typically a serum calcium level within the normal range.
- **Alkaline phosphatase:** May be monitored.
## Clinical Pearls
- Administer with meals to optimize phosphate binding.
- Monitor calcium-ionized levels, as total serum calcium can be misleading in patients with altered protein binding.
- Dose should be adjusted to maintain serum phosphate levels as close to normal (2.5-5.5 mg/dL) as possible without causing significant hypercalcemia.
***
*Disclaimer: This information is intended for clinical professionals and is not a substitute for professional medical advice. Always verify current prescribing information and consult with a qualified healthcare provider before making any treatment decisions.*